 SOUTH SAN FRANCISCO, Calif., Feb. 26, 2021 GLOBE NEWSWIRE -- Cytokinetics, Incorporated Nasdaq: CYTK today announced that on February 26, 2021 it granted stock options to purchase an aggregate of 9,000 shares of common stock to Wing Keung Chiu, a new employee whose employment commenced in February 2021 as a material inducement to his employment. The grant was previously approved by the Compensation and Talent Committee of Cytokinetics Board of Directors under the companys Amended and Restated 2004 Equity Incentive Plan. 